Suchergebnisse - "Kumar, Nathella Pavan"

PubPharm (6)

1

Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors

enthalten in: The Journal of infection | 2017

von Kumar, N. | Moideen, K. | Sivakumar, S. | +4

2

Influence of diabetes mellitus on immunity to human tuberculosis

enthalten in: Immunology | 2017

von Kumar Nathella, P. | Babu, S.

3

Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines

enthalten in: Tuberculosis (Edinburgh, Scotland) | 2015

von Kumar, N. | Banurekha, V. | Nair, D. | +3

4

Profiling leucocyte subsets in tuberculosis–diabetes co‐morbidity

enthalten in: Immunology | 2015

von Kumar, N. | Moideen, K. | Dhakshinraj, S. | +5

5

Diminished Systemic and Antigen-Specific Type 1, Type 17, and Other Proinflammatory Cytokines in Diabetic and Prediabetic Individuals With Latent Mycobacterium tuberculosis Infection

Erschienen: 2014

von Kumar, N. | George, P. | Kumaran, P. | +3

6

Expansion of Pathogen-Specific T-Helper 1 and T-Helper 17 Cells in Pulmonary Tuberculosis With Coincident Type 2 Diabetes Mellitus

Erschienen: 2013

von Kumar, N. | Sridhar, R. | Banurekha, V. | +3

1
[1]